FDA approves first GLP-1 pill for obesity from Wegovy maker Novo NordiskThe approval gives Novo Nordisk a head start over chief rival Eli Lilly, which is racing to launch its own obesity pill.{}

The approval gives Novo Nordisk a head start over chief rival Eli Lilly, which is racing to launch its own obesity pill.https://www.cnbc.com/2025/12/22/fda-approves-first-glp-1-pill-for-obesity-from-novo-nordisk.html